-
assays, Reporter assays, Polysome fractionation, DNA cloning. Cell Biology: Immunofluorescence, Live cell imaging. Screening assays: Next Generation Sequencing (RNAseq, ChIP-seq, single cell RNAseq, etc
-
the development of novel therapies for coronary microvascular disease. The research program focuses on clinical translation and the development and validation of existing and novel cardiac imaging-based
-
cell biology. Additional preferred qualifications include: experience in mouse models of disease, flow cytometry, single-cell RNA sequencing analysis, and image processing and analysis. Qualified
-
brainstem neurons as required. Engage in immunohistochemical staining, fluorescence microscopy, and other standard wet laboratory procedures, including solution preparation, different imaging approaches, and
-
and application of imaging methods for pulmonary disease, with a particular emphasis on magnetic resonance (MR) imaging using hyperpolarized 129Xe gas. The initial appointment will be for 1 year, with
-
that will be employed include flow cytometry, confocal and electron microscopy, in vivo two photon imaging, behavioral studies and transcriptomic techniques. The successful candidate will join the Center
-
, AI systems, and network science. Anticipated hiring range: $60K Benefits Include: The choice between 3 different health plans; vision and dental insurance; life insurance; benefits savings accounts
-
and imaging mass cytometry, and RNA sequencing. Disease areas of interest are fibrotic lung diseases such as idiopathic pulmonary fibrosis, pulmonary graft-vs-host disease, acute respiratory distress